Articles Tagged With: COVID-19
-
COVID-19 Infection Course Worse in Patients Receiving Anti-CD20 Treatment
In this retrospective cohort, patients receiving anti-CD20 treatment had worse clinical outcomes, including mortality, in addition to longer durations of infectivity and higher rates of relapse.
-
Outcomes of COVID-19-Associated Acute Myocarditis
In a review of COVID-19-associated acute myocarditis, investigators learned it is a rare complication that can occur without concomitant pneumonia, and frequently presents as cardiogenic shock. With supportive therapy, the short-term mortality rate is low.
-
The Darkest Hour: Little PPE, No Vaccine Led to Moral Injury
A fascinating and disturbing study captures the emotions and attitudes of healthcare workers in 2020 when COVID-19 emerged. Personal protective equipment was in short supply, and the first COVID-19 vaccines would not be available until the end of the year. There was a general despairing feeling in this period that there was not “enough” of anything, including reliable information.
-
Moral Injury in HCWs at Level of Combat Vets
Moral injury is a fairly well-established syndrome in combat soldiers, but researchers found healthcare workers suffered a comparable level of mental turmoil and ethical conflict during the first two years of the pandemic.
-
Survey: 87% of Acute Care Sites Short of Nurses
Healthcare delivery is at a critical tipping point due to a nursing shortage crisis that is projected to get worse, and no clear consensus on new labor models to meet the crisis, according to a survey and report by two companies involved in medical education and labor solutions. Even before the pandemic drove workers from the clinical bedside, experts projected 1 million more nurses would be needed by 2030.
-
Healthcare Workers Likely Will Be Offered New Vaccine
Healthcare workers likely will be offered a new COVID-19 vaccine the FDA is pushing to roll out for this fall and winter. The FDA Vaccines and Related Biological Products Advisory Committee approved “the inclusion of a SARS-CoV-2 omicron component for COVID-19 booster vaccines in the United States.”
-
COVID-19: Duration of Shedding of Transmissible Virus
Patients with COVID-19 were found, by culture, to shed replication-competent virus after an initial PCR test for median durations of four to five days.
-
COVID-19 Rebound
Symptomatic and virologic recrudescence after treatment of patients with COVID-19 with Paxlovid occurs in a tiny percentage of patients and generally is mild and self-limited.
-
Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373)
Novavax is authorized to be administered to patients age 18 years and older for active immunization to prevent COVID-19 caused by SARS-CoV-2.
-
Vaccinate Children Against MIS-C, a Serious Post-COVID Syndrome
COVID-19 vaccination can greatly reduce multisystem inflammatory syndrome in children, a rare but serious complication associated with SARS-CoV-2 infection, researchers are finding.